Literature DB >> 8118808

Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat.

C Ip1, M Singh, H J Thompson, J A Scimeca.   

Abstract

Conjugated linoleic acid (CLA) is a collective term which refers to a mixture of positional and geometric isomers of linoleic acid. It is naturally occurring in meat and dairy products. We have previously reported (Ip, C., Chin, S. F., Scimeca, J. A., and Pariza, M. W. Cancer Res., 51: 6118-6124, 1991) that 1% CLA in the diet suppressed mammary carcinogenesis in rats given a high dose (10 mg) of 7,12-dimethylbenz(a)anthracene. In the present study, dietary CLA between 0.05 and 0.5% was found to produce a dose-dependent inhibition in mammary tumor yield when fed chronically to rats treated with a lower dose (5 mg) of 7,12-dimethylbenz(a)anthracene. Short-term CLA feeding for 5 weeks, from weaning to the time of carcinogen administration at 50 days of age, also offered significant protection against subsequent tumor occurrence. This period corresponds to maturation of the mammary gland to the adult stage in the rat. The inhibitory response to short-term CLA exposure was observed with the use of 2 different carcinogens: 7,12-dimethylbenz(a)anthracene and methylnitrosourea. The fact that CLA was protective in the methylnitrosourea model suggests that it may have a direct modulating effect on susceptibility of the target organ to neoplastic transformation. The proliferative activity of the mammary epithelium was assessed by the incorporation of bromodeoxyuridine. Immunohistochemical staining results showed that CLA reduced the labeling index of the lobuloalveolar compartment, but not that of the ductal compartment of the mammary tree. Since the lobuloalveolar structures are derived from the terminal end buds which are the sites of carcinogenic transformation, the above finding is consistent with the bioassay data of tumor inhibition. Thus, changes in gland development and morphogenesis may be a locus of action of CLA in modulating mammary carcinogenesis. CLA is a unique anticarcinogen because it is present in foods from animal sources. Furthermore, its efficacy in cancer protection is manifest at dietary concentrations which are close to the levels consumed by humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118808

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  67 in total

1.  Effect of linoleic acid concentration on conjugated linoleic acid production by Butyrivibrio fibrisolvens A38.

Authors:  Y J Kim; R H Liu; D R Bond; J B Russell
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

Review 2.  Lipids in human milk.

Authors:  R G Jensen
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

3.  Geometry of conjugated double bonds of CLA isomers in a commercial mixture and in their hepatic 20:4 metabolites.

Authors:  J L Sébédio; P Juanéda; S Grégoire; J M Chardigny; J C Martin; C Ginies
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

4.  Dietary conjugated linoleic acid increases endurance capacity and fat oxidation in mice during exercise.

Authors:  Wataru Mizunoya; Satoshi Haramizu; Tetsuro Shibakusa; Yuki Okabe; Tohru Fushiki
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

5.  Inhibition of phospholipase A(2) activity by conjugated linoleic acids in human macrophages.

Authors:  Ewa Stachowska; Violetta Dziedziejko; Krzysztof Safranow; Izabela Gutowska; Grazyna Adler; Andrzej Ciechanowicz; Bogusław Machaliński; Dariusz Chlubek
Journal:  Eur J Nutr       Date:  2006-12-11       Impact factor: 5.614

6.  The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium.

Authors:  Margot M Ip; Sibel O McGee; Patricia A Masso-Welch; Clement Ip; Xiaojing Meng; Lihui Ou; Suzanne F Shoemaker
Journal:  Carcinogenesis       Date:  2007-01-27       Impact factor: 4.944

7.  Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Authors:  Christina Donnelly; Arne M Olsen; Lionel D Lewis; Burton L Eisenberg; Alan Eastman; William B Kinlaw
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

8.  Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901.

Authors:  Bing-Qing Chen; Yan-Mei Yang; Yan-Hui Gao; Jia-Ren Liu; Ying-Ben Xue; Xuan-Lin Wang; Yu-Mei Zheng; Jing-Shu Zhang; Rui-Hai Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  Oleic acid prevents apoptotic cell death induced by trans10, cis12 isomer of conjugated linoleic acid via p38 MAP kinase dependent pathway.

Authors:  Masao Yamasaki; Hirofumi Tachibana; Arisa Yamada; Yukari Ochi; Harishkumar Madhyastha; Kazuo Nishiyama; Koji Yamada
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-21       Impact factor: 2.416

Review 10.  Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks.

Authors:  D S Kelley; K L Erickson
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.